Harmony Biosciences Holdings Stock News

PLYMOUTH MEETING, Pa., March 9, 2022 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony" or the "Company") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializin

HRMY earnings call for the period ending December 31, 2021.

HRMY earnings call for the period ending December 31, 2021.

Harmony Biosciences (NASDAQ: HRMY ) reported its Q4 earnings results on Monday, February 28, 2022 at 07:30 AM. Here''s what investors need to know about the announcement. Earnings Harmony Biosciences beat estimated earnings by 70.27%, reporting an EPS of $0.63 versus … Full story available on Benzinga.com

Harmony Biosciences Holdings, Inc. (HRMY) CEO John Jacobs on Q4 2021 Results - Earnings Call Transcript

Harmony Biosciences Holdings, Inc. (HRMY) delivered earnings and revenue surprises of 96.88% and 3.15%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead

Harmony Biosciences press release (HRMY): Q4 Non-GAAP EPS of $0.63 beats by $0.12.Revenue of $91.21M (+62.0% Y/Y) beats by $1.68M.

WAKIX® (pitolisant) Net Revenue Increased 62% Year-over-Year to $91.2 Million for Fourth Quarter 2021 and 91% to $305.4 Million for Full Year

WAKIX ® (pitolisant) Net Revenue Increased 62% Year-over-Year to $91.2 Million for Fourth Quarter 2021 and 91% to $305.4 Million for Full Year

PLYMOUTH MEETING, Pa., Feb. 14, 2022 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases, today announced that it will issue a…

PLYMOUTH MEETING, Pa., Feb. 14, 2022 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative the

Harmony Biosciences Holdings Inc (HRMY) shares closed today at 1.1% below its 52 week high of $44.39, giving the company a market cap of $2B. The stock is currently up 21.4% year-to-date, up 20.3% over the past 12 months, and up 18.6% over the past five years. This week, the Dow Jones Industrial Average rose 1.6%, and the S&P 500 rose 2.3%. Trading Activity Trading volume this week was 7.1% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.9. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -323.0% The company's stock price performance over the past 12 months beats the peer average by -272.4% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.